EC Clinical and Medical Case Reports

Background: High population with low middle income for a country like Egypt might create a challenge on health care system resources and effect on prioritization of health system needs. With critical products like blood derivatives several elements might affect accessibility for these products.

Objective: The objective for this research is analyzing from policy prospective these elements in order to enhance accessibility for the patients which will lead to system enhancement.

Methods: Integration between survey analysis for 125 of health care professionals in Egypt including (Physicians, pharmacists, supply chain managers and payers) plus stock and sales analysis for previous 5 years. One way sensitivity analysis was conducted for robustness of data guaranteeing.

Results: The following results were found are discussed in result section.

Conclusion: Localization of blood derivatives manufacturing process might enhance accessibility through controlling of prices plus availability enhancement which will lead to resources utilization.

Keywords: Blood Derivatives Accessibility; Egypt; Abdalla Abotaleb

1. Roberts DJ., et al. “Problems and Approaches for Blood Transfusion in the Developing Countries”. Hematology/Oncology Clinics of North America 2 (2016): 477-495.
2. Kralievits KE., et al. “The global blood supply: a literature review”. Lancet2 (2015): S28.
3. Dzik WS., et al. “Transfusion Medicine in Sub-Saharan Africa: Conference Summary”. Transfusion Medicine Reviews 3 (2015): 195-204.
4. Ifland L. “Promoting national blood systems in developing countries”. Current Opinion in Hematology 6 (2014): 497-502.
5. Bates E. “Workshop on blood transfusion research in sub-Saharan Africa Pretoria, South Africa” (2015).
6. Sampson UK., et al. “Implementation Research: The Fourth Movement of the Unfinished Translation Research Symphony”. Global Heart 1 (2016): 153-158.
7. Peters DH., et al. “Implementation research: what it is and how to do it”. British Medical Journal 347 (2013): f6753.
8. Brown CH., et al. “An Overview of Research and Evaluation Designs for Dissemination and Implementation”. Annual Review of Public Health 38 (2017): 1-22.
9. Engelgau MM., et al. “Perspectives from NHLBI Global Health Think Tank Meeting for Late Stage (T4) Translation Research”. Global Heart 7 (2016): 21.
10. Westfall JM and Mensah GA. “T4 Translational Moonshot: Making Cardiovascular Discoveries Work for Everyone”. Circulation Research 2 (2018): 210-212.
11. Global Status Report on Blood Safety and Availability WHO (2016).